no code implementations • 23 Apr 2022 • Ferenc A. Bartha, Nóra Juhász, Sadegh Marzban, Renji Han, Gergely Röst
Paxlovid is a promising, orally bioavailable novel drug for SARS--CoV--2 with excellent safety profiles.
